Corvus Pharmaceuticals CRVS Software and Technology Licenses, Net
Software and Technology Licenses, Net at other companies
Other financials
Where this comes from
Reported directly by Corvus Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The official record: Corvus Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Corvus Pharmaceuticals's software and technology licenses, net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Corvus Pharmaceuticals's software and technology licenses, net?
- Corvus Pharmaceuticals (CRVS) reported software and technology licenses, net of $1.72M in Q1 2026.
- How has Corvus Pharmaceuticals's software and technology licenses, net changed year-over-year?
- Corvus Pharmaceuticals's software and technology licenses, net increased by 173.4% year-over-year, from $629K to $1.72M.
- What is the long-term trend for Corvus Pharmaceuticals's software and technology licenses, net?
- Over 5 years (2020 to 2025), Corvus Pharmaceuticals's software and technology licenses, net has grown at a 15.6% compound annual growth rate (CAGR), from $414K to $855K.